152 related articles for article (PubMed ID: 23340194)
1. The effects of an RGD-PAMAM dendrimer conjugate in 3D spheroid culture on cell proliferation, expression and aggregation.
Jiang LY; Lv B; Luo Y
Biomaterials; 2013 Apr; 34(11):2665-73. PubMed ID: 23340194
[TBL] [Abstract][Full Text] [Related]
2. Arginine-glycine-aspartic acid-polyethylene glycol-polyamidoamine dendrimer conjugate improves liver-cell aggregation and function in 3-D spheroid culture.
Chen Z; Lian F; Wang X; Chen Y; Tang N
Int J Nanomedicine; 2016; 11():4247-59. PubMed ID: 27621619
[TBL] [Abstract][Full Text] [Related]
3. Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures.
Hill E; Shukla R; Park SS; Baker JR
Bioconjug Chem; 2007; 18(6):1756-62. PubMed ID: 17970585
[TBL] [Abstract][Full Text] [Related]
4. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.
Waite CL; Roth CM
Bioconjug Chem; 2009 Oct; 20(10):1908-16. PubMed ID: 19775120
[TBL] [Abstract][Full Text] [Related]
5. Mixed-ligand modification of polyamidoamine dendrimers to develop an effective scaffold for maintenance of hepatocyte spheroids.
Higashiyama S; Noda M; Kawase M; Yagi K
J Biomed Mater Res A; 2003 Mar; 64(3):475-82. PubMed ID: 12579561
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery.
Yang H; Kao WJ
Int J Nanomedicine; 2007; 2(1):89-99. PubMed ID: 17722516
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.
Wang B; Navath RS; Romero R; Kannan S; Kannan R
Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931
[TBL] [Abstract][Full Text] [Related]
8. Ligand Accessibility and Bioactivity of a Hormone-Dendrimer Conjugate Depend on pH and pH History.
Kim SH; Madak-Erdogan Z; Bae SC; Carlson KE; Mayne CG; Granick S; Katzenellenbogen BS; Katzenellenbogen JA
J Am Chem Soc; 2015 Aug; 137(32):10326-35. PubMed ID: 26186415
[TBL] [Abstract][Full Text] [Related]
9. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
10. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes.
Muñoz AM; Fragoso-Vázquez MJ; Martel BP; Chávez-Blanco A; Dueñas-González A; R García-Sánchez J; Bello M; Romero-Castro A; Correa-Basurto J
Anticancer Agents Med Chem; 2020; 20(15):1857-1872. PubMed ID: 32324521
[TBL] [Abstract][Full Text] [Related]
11. Gene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers.
Pandita D; Santos JL; Rodrigues J; Pêgo AP; Granja PL; Tomás H
Biomacromolecules; 2011 Feb; 12(2):472-81. PubMed ID: 21210673
[TBL] [Abstract][Full Text] [Related]
12. GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists.
Kecskés A; Tosh DK; Wei Q; Gao ZG; Jacobson KA
Bioconjug Chem; 2011 Jun; 22(6):1115-27. PubMed ID: 21539392
[TBL] [Abstract][Full Text] [Related]
13. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.
Shukla R; Thomas TP; Peters J; Kotlyar A; Myc A; Baker JR
Chem Commun (Camb); 2005 Dec; (46):5739-41. PubMed ID: 16307130
[TBL] [Abstract][Full Text] [Related]
15. Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors.
Hennig R; Veser A; Kirchhof S; Goepferich A
Mol Pharm; 2015 Sep; 12(9):3292-302. PubMed ID: 26252154
[TBL] [Abstract][Full Text] [Related]
16. Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation.
Bosnjakovic A; Mishra MK; Ren W; Kurtoglu YE; Shi T; Fan D; Kannan RM
Nanomedicine; 2011 Jun; 7(3):284-94. PubMed ID: 21059404
[TBL] [Abstract][Full Text] [Related]
17. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
18. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
19. Effects of Polyamidoamine Dendrimers on a 3-D Neurosphere System Using Human Neural Progenitor Cells.
Zeng Y; Kurokawa Y; Zeng Q; Win-Shwe TT; Nansai H; Zhang Z; Sone H
Toxicol Sci; 2016 Jul; 152(1):128-44. PubMed ID: 27125967
[TBL] [Abstract][Full Text] [Related]
20. Three dimensional spheroid cell culture for nanoparticle safety testing.
Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
